Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
A

Intro to Myeloproliferative Neoplasms Classification

By Indy Hematology Review FEATURING Ayalew Tefferi
May 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

15:59
Dana-Farber Cancer Institute

What's New in AML: Approach to Relapsed and Refractory Disease

Feat. M. Luskin

Featured Video

18:46
What's New in AML Post ASCO 2019: BCL-2 Inhibitors

New Targets for Acute Myeloid Leukemia: FLT3, IDH1 &IDH2, CD33, BCL-2, H...

Feat. E. Wang
MPN
10:54
Indy Hematology Review

Jak2 inhibitor therapy for Polychthemia Vera

Feat. J. Mascarenhas
01:57
Indy Hematology Review

Jak2 inhibitor therapy for Essential thrombocythemia : MAJIC Study

Feat. J. Mascarenhas
05:14
Indy Hematology Review

Jak2 Inhibitors in Myelofibrosis

Feat. J. Mascarenhas
02:58
Indy Hematology Review

Ruxolitinib based combination therapy in MPN

Feat. J. Mascarenhas
03:57
Indy Hematology Review

JAK2 inhibitors in MPN questions

Feat. J. Mascarenhas
06:50
Indy Hematology Review

Intro to Myeloproliferative Neoplasms Classification

Feat. A. Tefferi
05:35
Indy Hematology Review

Intro to practical diagnostic algorithm for Myeloproliferative neoplasms

Feat. A. Tefferi
09:29
Indy Hematology Review

Intro to treatment algorithm for Myeloproliferative Neoplasms

Feat. A. Tefferi